These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 2138609
1. Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition. Derechin VM, Blinder MA, Tollefsen DM. J Biol Chem; 1990 Apr 05; 265(10):5623-8. PubMed ID: 2138609 [Abstract] [Full Text] [Related]
2. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans. Van Deerlin VM, Tollefsen DM. J Biol Chem; 1991 Oct 25; 266(30):20223-31. PubMed ID: 1939083 [Abstract] [Full Text] [Related]
3. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II. Blinder MA, Tollefsen DM. J Biol Chem; 1990 Jan 05; 265(1):286-91. PubMed ID: 2104620 [Abstract] [Full Text] [Related]
6. Heparin facilitates dissociation of complexes between thrombin and a reactive site mutant (L444R) of heparin cofactor II. Han JH, Van Deerlin VM, Tollefsen DM. J Biol Chem; 1997 Mar 28; 272(13):8243-9. PubMed ID: 9079643 [Abstract] [Full Text] [Related]
7. Heparin promotes proteolytic inactivation by thrombin of a reactive site mutant (L444R) of recombinant heparin cofactor II. Ciaccia AV, Willemze AJ, Church FC. J Biol Chem; 1997 Jan 10; 272(2):888-93. PubMed ID: 8995378 [Abstract] [Full Text] [Related]
8. Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition. Mitchell JW, Church FC. J Biol Chem; 2002 May 31; 277(22):19823-30. PubMed ID: 11856753 [Abstract] [Full Text] [Related]
10. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity. Sheehan JP, Wu Q, Tollefsen DM, Sadler JE. J Biol Chem; 1993 Feb 15; 268(5):3639-45. PubMed ID: 8429040 [Abstract] [Full Text] [Related]
12. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition. Filion ML, Bhakta V, Nguyen LH, Liaw PS, Sheffield WP. Biochemistry; 2004 Nov 23; 43(46):14864-72. PubMed ID: 15544357 [Abstract] [Full Text] [Related]
18. The protease specificity of heparin cofactor II. Inhibition of thrombin generated during coagulation. Parker KA, Tollefsen DM. J Biol Chem; 1985 Mar 25; 260(6):3501-5. PubMed ID: 3838315 [Abstract] [Full Text] [Related]
19. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans. Sheehan JP, Tollefsen DM, Sadler JE. J Biol Chem; 1994 Dec 30; 269(52):32747-51. PubMed ID: 7806495 [Abstract] [Full Text] [Related]
20. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate. Ben Mansour M, Dhahri M, Vénisse L, Jandrot-Perrus M, Chaubet F, Maaroufi RM. Thromb Res; 2009 Apr 30; 123(6):902-8. PubMed ID: 19046760 [Abstract] [Full Text] [Related] Page: [Next] [New Search]